MILNACIPRAN Drug Patent Profile
✉ Email this page to a colleague
When do Milnacipran patents expire, and when can generic versions of Milnacipran launch?
Milnacipran is a drug marketed by Amneal Pharms, Breckenridge, and Hetero Labs Ltd V. and is included in three NDAs.
The generic ingredient in MILNACIPRAN is milnacipran hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the milnacipran hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Milnacipran
A generic version of MILNACIPRAN was approved as milnacipran hydrochloride by BRECKENRIDGE on January 27th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MILNACIPRAN?
- What are the global sales for MILNACIPRAN?
- What is Average Wholesale Price for MILNACIPRAN?
Summary for MILNACIPRAN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| DailyMed Link: | MILNACIPRAN at DailyMed |
US Patents and Regulatory Information for MILNACIPRAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | MILNACIPRAN HYDROCHLORIDE | milnacipran hydrochloride | TABLET;ORAL | 205081-001 | Apr 22, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Breckenridge | MILNACIPRAN HYDROCHLORIDE | milnacipran hydrochloride | TABLET;ORAL | 205071-003 | Jan 27, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Amneal Pharms | MILNACIPRAN HYDROCHLORIDE | milnacipran hydrochloride | TABLET;ORAL | 205081-004 | Apr 22, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hetero Labs Ltd V | MILNACIPRAN HYDROCHLORIDE | milnacipran hydrochloride | TABLET;ORAL | 205147-004 | Oct 3, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
